Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-12-27

FDA Approved: DEFERASIROX — Original Application (Amneal Pharmaceuticals NY LLC)

View source ↗

Summary

FDA approved the original application for deferasirox from Amneal Pharmaceuticals NY LLC, marking the first generic approval of deferasirox.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Deferasirox (Deferasirox)

Snippet

ORIG AP for DEFERASIROX (DEFERASIROX)